Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.

Patients with chronic obstructive pulmonary disease (COPD) describe their breathlessness as related to the work and effort associated with breathing. Current evidence suggests that the perception of dyspnea is due to a "mismatch" between the outgoing motor command from the central nervous system and the corresponding afferent information from chemoreceptors and/or mechanoreceptors. To measure the severity of dyspnea the principles of psychophysics (stimulus --> response relationship) can be applied. One approach is to consider activities of daily living as a putative stimulus. Although this method relies on patient recall and description of daily tasks, ability to function, as well as time and effort to complete an activity, select clinical instruments have demonstrated appropriate measurement criteria in randomized clinical trials involving patients with COPD. Another approach is for a patient to report the intensity of dyspnea during exercise, and current practice is to provide ratings each minute "on cue" during the exercise test. A computerized system has been developed whereby the person can report ratings spontaneously and continuously by moving a computer mouse that adjusts a vertical bar adjacent to 0-10 category-ratio scale positioned on a monitor. With this continuous method the patient reports twice the number of dyspnea ratings during exercise compared with discrete ratings each minute. Patient-reported dyspnea based on activities of daily living and exercise testing provides distinct but complimentary information.

[1]  F. Martinez,et al.  Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. , 1997, American journal of respiratory and critical care medicine.

[2]  M. Tabrizi,et al.  Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. , 2004, Chest.

[3]  J. A. Scott,et al.  Descriptors of breathlessness in cardiorespiratory diseases. , 1996, American journal of respiratory and critical care medicine.

[4]  J. Baird,et al.  exercise : validity , reliability , and responsiveness Continuous measurement of breathlessness during , 2001 .

[5]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[6]  G. Guyatt,et al.  Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ) , 2005, COPD.

[7]  J. Baird,et al.  Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. , 2004, Chest.

[8]  D. O’Donnell,et al.  The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. , 1995, American journal of respiratory and critical care medicine.

[9]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[10]  D. Mahler,et al.  Meaningful effect size and patterns of response of the transition dyspnea index. , 2003, Journal of clinical epidemiology.

[11]  J. Yates,et al.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[12]  J. Baird,et al.  Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD. , 2005, Medicine and science in sports and exercise.

[13]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[14]  S. Gandevia,et al.  Effect of increased lung volume on perception of breathlessness, effort, and tension. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[15]  N. Anthonisen,et al.  Effect of dynamic airway compression on breathing pattern and respiratory sensation in severe chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[16]  R. Aitken.  Measurement of feelings using visual analogue scales. , 1969, Proceedings of the Royal Society of Medicine.

[17]  G. Guyatt,et al.  A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire , 2005, European Respiratory Journal.

[18]  N. Cherniack,et al.  Psychological profile and ventilatory response to inspiratory resistive loading. , 2000, American journal of respiratory and critical care medicine.

[19]  T. Beroíza,et al.  Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device. , 1994, The European respiratory journal.

[20]  M. Artvinli,et al.  Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. , 1978, British medical journal.

[21]  D. Mahler,et al.  Target dyspnea ratings predict expected oxygen consumption as well as target heart rate values. , 1999, American journal of respiratory and critical care medicine.

[22]  D. O’Donnell,et al.  Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. , 1997, American journal of respiratory and critical care medicine.

[23]  R. Lansing,et al.  'Air hunger' from increased PCO2 persists after complete neuromuscular block in humans. , 1990, Respiration physiology.

[24]  J. Yernault,et al.  Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD. , 1992, The European respiratory journal.

[25]  J. Baird,et al.  Mechanisms and Measurement of Exertional Dyspnea , 2002 .

[26]  M. Morgan,et al.  Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation , 2003, Thorax.

[27]  M. Polkey,et al.  Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[28]  H. Manning,et al.  Pathophysiology of dyspnea. , 1995, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[29]  C. H. Wood,et al.  Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population , 1959, British medical journal.

[30]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[31]  D. O’Donnell,et al.  Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. , 1993, The American review of respiratory disease.

[32]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[33]  B. Make,et al.  Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.

[34]  Fletcher Cm.  The clinical diagnosis of pulmonary emphysema; an experimental study. , 1952 .

[35]  J. A. Daubenspeck,et al.  Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. , 2015, The American review of respiratory disease.

[36]  N. Leidy,et al.  The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. , 2003, Chest.

[37]  N. Jones,et al.  Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. , 1996, Chest.

[38]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[39]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[40]  D. Mahler,et al.  Minimal important difference of the transition dyspnoea index in a multinational clinical trial , 2003, European Respiratory Journal.

[41]  L. Adams,et al.  Comparison between continuous and discrete measurements of breathlessness during exercise in normal subjects using a visual analogue scale. , 1993, Clinical science.

[42]  N. Jones.  Clinical Exercise Testing , 1982 .

[43]  Cold facial stimulation reduces breathlessness induced in normal subjects. , 1987, The American review of respiratory disease.

[44]  R. Zuwallack,et al.  The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. , 1994, Chest.

[45]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[46]  John C. Baird,et al.  Fundamentals of scaling and psychophysics , 1978 .

[47]  A. Gift,et al.  Visual Analogue Scales: Measurement of Subjective Phenomena , 1989, Nursing research.

[48]  V. Carrieri-Kohlman,et al.  Differentiation between Dyspnea and Its Affective Components , 1996, Western journal of nursing research.

[49]  N. Jones,et al.  Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. , 1992, The American review of respiratory disease.

[50]  R. Kaplan,et al.  Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. , 1998, Chest.